Section

Clinical Trails

Latest updates, in-depth analysis, and breaking news on Clinical Trails

25 Stories

1 week ago Clinical Trails

J&J’s Spravato touts durable anti-depressant benefits in real-world study

Summary Johnson & Johnson has released new data from a major study regarding its depression treatment, Spravato. The study, known as the Phase IV ECHO tria...

Read Story

Roche drops Phase III plans for emugrobart in two muscle wasting diseases

Clinical Trails

Mar 20, 2026

Roche drops Phase III plans for emugrobart in two muscle wasting diseases

Summary The healthcare company Roche has decided to stop its plans for a final round of t...

Healthcare Times

Read

Clinical Trails

Mar 20, 2026

Greenwich adds City of Hope to FLAMINGO-01 trial for breast cancer

Summary Greenwich LifeSciences has officially added City of Hope to its ongoing Phase III...

Healthcare Times

Read

Shionogi enrols first patients in Esprit trial for Pompe disease

Clinical Trails

Mar 20, 2026

Shionogi enrols first patients in Esprit trial for Pompe disease

Summary The pharmaceutical company Shionogi has reached a major milestone in its search f...

Healthcare Times

Read

FDA outlines plan to phase out animal testing in new draft guidance

Clinical Trails

Mar 20, 2026

FDA outlines plan to phase out animal testing in new draft guidance

Summary The United States Food and Drug Administration (FDA) has released a new draft gui...

Healthcare Times

Read

Aspen’s personalised Parkinson’s cell therapy to advance to Phase III

Clinical Trails

Mar 19, 2026

Aspen’s personalised Parkinson’s cell therapy to advance to Phase III

Summary Aspen Neuroscience has announced that its personalized cell therapy for Parkinson...

Healthcare Times

Read

Population patterns of CKD: the role of age and sex

Clinical Trails

Mar 19, 2026

Population patterns of CKD: the role of age and sex

Summary Chronic Kidney Disease, often called CKD, is becoming a major health concern as t...

Healthcare Times

Read

Clinical Trails

Mar 19, 2026

Silent spread, serious consequences: the shifting trends of AMR

Summary Antimicrobial resistance, often called AMR, is becoming a much bigger threat to g...

Healthcare Times

Read

Rhythm’s Imcivree fails Phase III rare disease obesity trial

Clinical Trails

Mar 18, 2026

Rhythm’s Imcivree fails Phase III rare disease obesity trial

Summary Rhythm Pharmaceuticals recently shared disappointing news regarding its drug, Imc...

Healthcare Times

Read

Structure’s obesity pill prompts 16.3% weight loss in Phase II

Clinical Trails

Mar 18, 2026

Structure’s obesity pill prompts 16.3% weight loss in Phase II

Summary Structure Therapeutics recently shared positive results from a mid-stage clinical...

Healthcare Times

Read

Mirum concludes Phase III EXPAND trial enrolment for Livmarli

Clinical Trails

Mar 18, 2026

Mirum concludes Phase III EXPAND trial enrolment for Livmarli

Summary Mirum Pharmaceuticals has reached a major milestone by finishing the patient sign...

Healthcare Times

Read

Bayer eyes label expansion on Phase III non-diabetic CKD win

Clinical Trails

Mar 17, 2026

Bayer eyes label expansion on Phase III non-diabetic CKD win

Summary Bayer has announced positive results from a major clinical trial for its kidney d...

Healthcare Times

Read

Live Weather

Live

Explore Sections

Daily Briefing

Free Newsletter

Stay in the Loop

AI-curated stories delivered straight to your inbox every morning.

No spam · Unsubscribe anytime